![David Westberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Westberg
Directeur Général chez
NANEXA AB
Profil
David Westberg is currently the Chief Executive Officer & Managing Director at Nanexa AB since 2015.
He is also a Director at W & W Management & Design AB and an Independent Director at Lipigon Pharmaceuticals AB since 2023.
Previously, he worked as the Head-Product Development Department at Pharmacia AB, a Project Manager at Orexo AB, and a Manager-Project & Operations at LIDDS AB. Mr. Westberg graduated from the Royal Institute of Technology.
Postes actifs de David Westberg
| Sociétés | Poste | Début |
|---|---|---|
| NANEXA AB | Directeur Général | 01/04/2015 |
| LIPIGON PHARMACEUTICALS AB | Directeur/Membre du Conseil | 01/01/2023 |
W & W Management & Design AB | Directeur/Membre du Conseil | - |
Anciens postes connus de David Westberg
| Sociétés | Poste | Fin |
|---|---|---|
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
| OREXO AB | Corporate Officer/Principal | - |
| LIDDS AB | Directeur des opérations | - |
Formation de David Westberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Nanexa AB
 Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
W & W Management & Design AB | |
Lipigon Pharmaceuticals AB
 Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
